ID   ARNA_ECOLI              Reviewed;         660 AA.
AC   P77398; Q56VX0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=Bifunctional polymyxin resistance protein ArnA;
DE   AltName: Full=Polymyxin resistance protein PmrI;
DE   Includes:
DE     RecName: Full=UDP-4-amino-4-deoxy-L-arabinose formyltransferase;
DE              EC=2.1.2.13;
DE     AltName: Full=ArnAFT;
DE     AltName: Full=UDP-L-Ara4N formyltransferase;
DE   Includes:
DE     RecName: Full=UDP-glucuronic acid oxidase, UDP-4-keto-hexauronic acid decarboxylating;
DE              EC=1.1.1.305;
DE     AltName: Full=ArnADH;
DE     AltName: Full=UDP-GlcUA decarboxylase;
DE     AltName: Full=UDP-glucuronic acid dehydrogenase;
GN   Name=arnA; Synonyms=pmrI, yfbG; OrderedLocusNames=b2255, JW2249;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION OF C-TERMINAL DOMAIN, AND
RP   CHARACTERIZATION.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=11706007; DOI=10.1074/jbc.M109377200;
RA   Breazeale S.D., Ribeiro A.A., Raetz C.R.H.;
RT   "Oxidative decarboxylation of UDP-glucuronic acid in extracts of
RT   polymyxin-resistant Escherichia coli. Origin of lipid A species
RT   modified with 4-amino-4-deoxy-L-arabinose.";
RL   J. Biol. Chem. 277:2886-2896(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   INDUCTION BY BASR.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15569938; DOI=10.1073/pnas.0406038101;
RA   Winfield M.D., Groisman E.A.;
RT   "Phenotypic differences between Salmonella and Escherichia coli
RT   resulting from the disparate regulation of homologous genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:17162-17167(2004).
RN   [6]
RP   FUNCTION OF N-TERMINAL DOMAIN, CATALYTIC ACTIVITY, AND
RP   CHARACTERIZATION.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=15695810; DOI=10.1074/jbc.M414265200;
RA   Breazeale S.D., Ribeiro A.A., McClerren A.L., Raetz C.R.H.;
RT   "A formyltransferase required for polymyxin resistance in Escherichia
RT   coli and the modification of lipid A with 4-amino-4-deoxy-L-arabinose:
RT   identification and function of UDP-4-deoxy-4-formamido-L-arabinose.";
RL   J. Biol. Chem. 280:14154-14167(2005).
RN   [7]
RP   PATHWAY.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=17928292; DOI=10.1074/jbc.M706172200;
RA   Yan A., Guan Z., Raetz C.R.H.;
RT   "An undecaprenyl phosphate-aminoarabinose flippase required for
RT   polymyxin resistance in Escherichia coli.";
RL   J. Biol. Chem. 282:36077-36089(2007).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 306-660, CATALYTIC ACTIVITY
RP   OF C-TERMINAL DOMAIN, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15491143; DOI=10.1021/bi048551f;
RA   Gatzeva-Topalova P.Z., May A.P., Sousa M.C.;
RT   "Crystal structure of Escherichia coli ArnA (PmrI) decarboxylase
RT   domain. A key enzyme for lipid A modification with 4-amino-4-deoxy-L-
RT   arabinose and polymyxin resistance.";
RL   Biochemistry 43:13370-13379(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-300, MUTAGENESIS OF
RP   ASN-102; HIS-104 AND ASP-140, AND REACTION MECHASNISM.
RX   PubMed=15807526; DOI=10.1021/bi047384g;
RA   Gatzeva-Topalova P.Z., May A.P., Sousa M.C.;
RT   "Crystal structure and mechanism of the Escherichia coli ArnA (PmrI)
RT   transformylase domain. An enzyme for lipid A modification with 4-
RT   amino-4-deoxy-L-arabinose and polymyxin resistance.";
RL   Biochemistry 44:5328-5338(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) IN COMPLEX WITH UMP AND
RP   N-5-FTHF, AND MUTAGENESIS OF SER-433 AND GLU-434.
RX   PubMed=15809294; DOI=10.1074/jbc.M501534200;
RA   Williams G.J., Breazeale S.D., Raetz C.R.H., Naismith J.H.;
RT   "Structure and function of both domains of ArnA, a dual function
RT   decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-
RT   arabinose biosynthesis.";
RL   J. Biol. Chem. 280:23000-23008(2005).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) IN COMPLEX WITH UDP-GLCUA AND
RP   NAD ANALOG AND OF 306-660 OF MUTANTS ALA-433; GLU-619; MET-619 AND
RP   TYR-619, MUTAGENESIS OF SER-433 AND ARG-619, SUBUNIT, AND REACTION
RP   MECHANISM.
RX   PubMed=15939024; DOI=10.1016/j.str.2005.03.018;
RA   Gatzeva-Topalova P.Z., May A.P., Sousa M.C.;
RT   "Structure and mechanism of ArnA: conformational change implies
RT   ordered dehydrogenase mechanism in key enzyme for polymyxin
RT   resistance.";
RL   Structure 13:929-942(2005).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes the oxidative
CC       decarboxylation of UDP-glucuronic acid (UDP-GlcUA) to UDP-4-keto-
CC       arabinose (UDP-Ara4O) and the addition of a formyl group to UDP-4-
CC       amino-4-deoxy-L-arabinose (UDP-L-Ara4N) to form UDP-L-4-formamido-
CC       arabinose (UDP-L-Ara4FN). The modified arabinose is attached to
CC       lipid A and is required for resistance to polymyxin and cationic
CC       antimicrobial peptides. {ECO:0000269|PubMed:11706007,
CC       ECO:0000269|PubMed:15695810}.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucuronate + NAD(+) = UDP-beta-L-
CC       threo-pentapyranos-4-ulose + CO(2) + NADH.
CC   -!- CATALYTIC ACTIVITY: 10-formyltetrahydrofolate + UDP-4-amino-4-
CC       deoxy-beta-L-arabinose = 5,6,7,8-tetrahydrofolate + UDP-4-deoxy-4-
CC       formamido-beta-L-arabinose.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.76 mM for NAD {ECO:0000269|PubMed:15491143};
CC         KM=0.086 mM for UDP-GlcUA {ECO:0000269|PubMed:15491143};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-4-deoxy-4-formamido-
CC       beta-L-arabinose biosynthesis; UDP-4-deoxy-4-formamido-beta-L-
CC       arabinose from UDP-alpha-D-glucuronate: step 1/3.
CC       {ECO:0000269|PubMed:17928292}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-4-deoxy-4-formamido-
CC       beta-L-arabinose biosynthesis; UDP-4-deoxy-4-formamido-beta-L-
CC       arabinose from UDP-alpha-D-glucuronate: step 3/3.
CC       {ECO:0000269|PubMed:17928292}.
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; lipopolysaccharide
CC       biosynthesis. {ECO:0000269|PubMed:17928292}.
CC   -!- SUBUNIT: Homohexamer, formed by a dimer of trimers.
CC       {ECO:0000269|PubMed:15809294, ECO:0000269|PubMed:15939024}.
CC   -!- INDUCTION: Induced by BasR. {ECO:0000269|PubMed:15569938}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the Fmt family.
CC       UDP-L-Ara4N formyltransferase subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the NAD(P)-
CC       dependent epimerase/dehydratase family. UDP-glucuronic acid
CC       decarboxylase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY057445; AAL23678.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75315.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16078.1; -; Genomic_DNA.
DR   PIR; E64996; E64996.
DR   RefSeq; NP_416758.1; NC_000913.3.
DR   RefSeq; WP_000860273.1; NZ_LN832404.1.
DR   PDB; 1U9J; X-ray; 2.40 A; A=306-660.
DR   PDB; 1YRW; X-ray; 1.70 A; A=1-300.
DR   PDB; 1Z73; X-ray; 2.50 A; A=306-660.
DR   PDB; 1Z74; X-ray; 2.70 A; A=306-660.
DR   PDB; 1Z75; X-ray; 2.40 A; A=306-660.
DR   PDB; 1Z7B; X-ray; 2.31 A; A=306-660.
DR   PDB; 1Z7E; X-ray; 3.00 A; A/B/C/D/E/F=1-660.
DR   PDB; 2BLL; X-ray; 2.30 A; A=317-660.
DR   PDB; 2BLN; X-ray; 1.20 A; A/B=1-305.
DR   PDB; 4WKG; X-ray; 2.70 A; A/B/C/D/E/F=1-660.
DR   PDBsum; 1U9J; -.
DR   PDBsum; 1YRW; -.
DR   PDBsum; 1Z73; -.
DR   PDBsum; 1Z74; -.
DR   PDBsum; 1Z75; -.
DR   PDBsum; 1Z7B; -.
DR   PDBsum; 1Z7E; -.
DR   PDBsum; 2BLL; -.
DR   PDBsum; 2BLN; -.
DR   PDBsum; 4WKG; -.
DR   ProteinModelPortal; P77398; -.
DR   SMR; P77398; -.
DR   BioGrid; 4260497; 259.
DR   DIP; DIP-11961N; -.
DR   IntAct; P77398; 14.
DR   MINT; MINT-1257581; -.
DR   STRING; 511145.b2255; -.
DR   DrugBank; DB03256; (6R)-Folinic acid.
DR   DrugBank; DB03685; Uridine-5'-Monophosphate.
DR   EPD; P77398; -.
DR   PaxDb; P77398; -.
DR   PRIDE; P77398; -.
DR   EnsemblBacteria; AAC75315; AAC75315; b2255.
DR   EnsemblBacteria; BAA16078; BAA16078; BAA16078.
DR   GeneID; 947683; -.
DR   KEGG; ecj:JW2249; -.
DR   KEGG; eco:b2255; -.
DR   PATRIC; 32119875; VBIEscCol129921_2347.
DR   EchoBASE; EB3844; -.
DR   EcoGene; EG14091; arnA.
DR   eggNOG; ENOG4105C3I; Bacteria.
DR   eggNOG; COG0223; LUCA.
DR   eggNOG; COG0451; LUCA.
DR   HOGENOM; HOG000247761; -.
DR   InParanoid; P77398; -.
DR   KO; K10011; -.
DR   OMA; VRYCVKY; -.
DR   PhylomeDB; P77398; -.
DR   BioCyc; EcoCyc:G7168-MONOMER; -.
DR   BioCyc; MetaCyc:G7168-MONOMER; -.
DR   BRENDA; 1.1.1.305; 2026.
DR   BRENDA; 2.1.2.13; 2026.
DR   SABIO-RK; P77398; -.
DR   UniPathway; UPA00030; -.
DR   UniPathway; UPA00032; UER00492.
DR   UniPathway; UPA00032; UER00494.
DR   EvolutionaryTrace; P77398; -.
DR   PRO; PR:P77398; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0016742; F:hydroxymethyl-, formyl- and related transferase activity; IDA:EcoCyc.
DR   GO; GO:0070403; F:NAD+ binding; IDA:UniProtKB.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IDA:EcoCyc.
DR   GO; GO:0099619; F:UDP-4-amino-4-deoxy-L-arabinose formyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0048040; F:UDP-glucuronate decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0099618; F:UDP-glucuronic acid dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0009245; P:lipid A biosynthetic process; IDA:EcoCyc.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046677; P:response to antibiotic; IDA:EcoCyc.
DR   GO; GO:0033320; P:UDP-D-xylose biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.10.25.10; -; 1.
DR   Gene3D; 3.40.50.170; -; 1.
DR   Gene3D; 3.40.50.720; -; 1.
DR   HAMAP; MF_01166; ArnA; 1.
DR   InterPro; IPR021168; Bifun_polymyxin_resist_ArnA.
DR   InterPro; IPR001509; Epimerase_deHydtase.
DR   InterPro; IPR005793; Formyl_trans_C.
DR   InterPro; IPR002376; Formyl_transf_N.
DR   InterPro; IPR011034; Formyl_transferase_C-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF01370; Epimerase; 1.
DR   Pfam; PF02911; Formyl_trans_C; 1.
DR   Pfam; PF00551; Formyl_trans_N; 1.
DR   PIRSF; PIRSF036506; Bifun_polymyxin_resist_ArnA; 1.
DR   SUPFAM; SSF50486; SSF50486; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF53328; SSF53328; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic resistance; Complete proteome;
KW   Lipid A biosynthesis; Lipid biosynthesis; Lipid metabolism;
KW   Lipopolysaccharide biosynthesis; Multifunctional enzyme; NAD;
KW   Oxidoreductase; Reference proteome; Transferase.
FT   CHAIN         1    660       Bifunctional polymyxin resistance protein
FT                                ArnA.
FT                                /FTId=PRO_0000083098.
FT   NP_BIND     368    369       NAD binding.
FT   REGION        1    304       Formyltransferase ArnAFT.
FT   REGION       86     88       10-formyltetrahydrofolate binding.
FT   REGION      136    140       10-formyltetrahydrofolate binding.
FT   REGION      314    660       Dehydrogenase ArnADH.
FT   REGION      432    433       UDP-glucuronate binding.
FT   REGION      526    535       UDP-glucuronate binding.
FT   ACT_SITE    104    104       Proton donor; for formyltransferase
FT                                activity.
FT   ACT_SITE    434    434       Proton acceptor; for decarboxylase
FT                                activity.
FT   ACT_SITE    619    619       Proton donor; for decarboxylase activity.
FT   BINDING     114    114       10-formyltetrahydrofolate.
FT   BINDING     347    347       NAD.
FT   BINDING     393    393       UDP-glucuronate; via carbonyl oxygen.
FT   BINDING     398    398       UDP-glucuronate.
FT   BINDING     460    460       UDP-glucuronate.
FT   BINDING     492    492       UDP-glucuronate.
FT   BINDING     613    613       UDP-glucuronate.
FT   SITE        102    102       Transition state stabilizer.
FT   SITE        140    140       Raises pKa of active site His.
FT   MUTAGEN     102    102       N->A: No activity.
FT                                {ECO:0000269|PubMed:15807526}.
FT   MUTAGEN     104    104       H->A: 25-fold lower activity.
FT                                {ECO:0000269|PubMed:15807526}.
FT   MUTAGEN     104    104       H->K: Less than 1% residual activity.
FT                                {ECO:0000269|PubMed:15807526}.
FT   MUTAGEN     140    140       D->A,N: Less than 1% residual activity.
FT                                {ECO:0000269|PubMed:15807526}.
FT   MUTAGEN     433    433       S->A: 40-fold lower specific activity.
FT                                {ECO:0000269|PubMed:15809294,
FT                                ECO:0000269|PubMed:15939024}.
FT   MUTAGEN     433    433       S->T: No activity.
FT                                {ECO:0000269|PubMed:15809294,
FT                                ECO:0000269|PubMed:15939024}.
FT   MUTAGEN     434    434       E->A: 100-fold lower specific activity.
FT                                {ECO:0000269|PubMed:15809294}.
FT   MUTAGEN     434    434       E->Q: No activity.
FT                                {ECO:0000269|PubMed:15809294}.
FT   MUTAGEN     619    619       R->E,Y: No activity.
FT                                {ECO:0000269|PubMed:15939024}.
FT   MUTAGEN     619    619       R->M: 400-fold lower activity.
FT                                {ECO:0000269|PubMed:15939024}.
FT   STRAND        2      7       {ECO:0000244|PDB:2BLN}.
FT   HELIX         9     21       {ECO:0000244|PDB:2BLN}.
FT   STRAND       25     30       {ECO:0000244|PDB:2BLN}.
FT   HELIX        45     52       {ECO:0000244|PDB:2BLN}.
FT   HELIX        65     73       {ECO:0000244|PDB:2BLN}.
FT   STRAND       77     83       {ECO:0000244|PDB:2BLN}.
FT   HELIX        90     93       {ECO:0000244|PDB:2BLN}.
FT   STRAND      100    106       {ECO:0000244|PDB:2BLN}.
FT   TURN        108    111       {ECO:0000244|PDB:2BLN}.
FT   STRAND      112    114       {ECO:0000244|PDB:2BLN}.
FT   HELIX       116    122       {ECO:0000244|PDB:2BLN}.
FT   STRAND      126    134       {ECO:0000244|PDB:2BLN}.
FT   TURN        139    141       {ECO:0000244|PDB:1Z7E}.
FT   STRAND      144    151       {ECO:0000244|PDB:2BLN}.
FT   HELIX       158    181       {ECO:0000244|PDB:2BLN}.
FT   HELIX       192    194       {ECO:0000244|PDB:2BLN}.
FT   HELIX       203    206       {ECO:0000244|PDB:2BLN}.
FT   HELIX       214    223       {ECO:0000244|PDB:2BLN}.
FT   STRAND      231    235       {ECO:0000244|PDB:2BLN}.
FT   STRAND      238    248       {ECO:0000244|PDB:2BLN}.
FT   STRAND      258    261       {ECO:0000244|PDB:2BLN}.
FT   TURN        262    264       {ECO:0000244|PDB:2BLN}.
FT   STRAND      265    268       {ECO:0000244|PDB:2BLN}.
FT   STRAND      270    281       {ECO:0000244|PDB:2BLN}.
FT   HELIX       289    296       {ECO:0000244|PDB:2BLN}.
FT   STRAND      299    301       {ECO:0000244|PDB:1Z7E}.
FT   STRAND      317    322       {ECO:0000244|PDB:2BLL}.
FT   HELIX       326    337       {ECO:0000244|PDB:2BLL}.
FT   STRAND      342    348       {ECO:0000244|PDB:2BLL}.
FT   HELIX       351    356       {ECO:0000244|PDB:2BLL}.
FT   STRAND      362    366       {ECO:0000244|PDB:2BLL}.
FT   TURN        369    371       {ECO:0000244|PDB:2BLL}.
FT   HELIX       374    382       {ECO:0000244|PDB:2BLL}.
FT   STRAND      384    388       {ECO:0000244|PDB:2BLL}.
FT   HELIX       395    400       {ECO:0000244|PDB:2BLL}.
FT   HELIX       402    409       {ECO:0000244|PDB:2BLL}.
FT   HELIX       411    422       {ECO:0000244|PDB:2BLL}.
FT   STRAND      426    430       {ECO:0000244|PDB:2BLL}.
FT   HELIX       433    436       {ECO:0000244|PDB:2BLL}.
FT   STRAND      442    444       {ECO:0000244|PDB:2BLL}.
FT   TURN        446    448       {ECO:0000244|PDB:2BLL}.
FT   STRAND      451    453       {ECO:0000244|PDB:4WKG}.
FT   HELIX       459    461       {ECO:0000244|PDB:2BLL}.
FT   HELIX       462    481       {ECO:0000244|PDB:2BLL}.
FT   STRAND      485    490       {ECO:0000244|PDB:2BLL}.
FT   STRAND      492    494       {ECO:0000244|PDB:2BLL}.
FT   STRAND      504    506       {ECO:0000244|PDB:2BLL}.
FT   HELIX       510    521       {ECO:0000244|PDB:2BLL}.
FT   STRAND      525    527       {ECO:0000244|PDB:2BLL}.
FT   HELIX       528    530       {ECO:0000244|PDB:2BLL}.
FT   STRAND      534    536       {ECO:0000244|PDB:2BLL}.
FT   HELIX       540    552       {ECO:0000244|PDB:2BLL}.
FT   HELIX       554    556       {ECO:0000244|PDB:2BLL}.
FT   TURN        557    560       {ECO:0000244|PDB:2BLL}.
FT   STRAND      561    565       {ECO:0000244|PDB:2BLL}.
FT   STRAND      570    573       {ECO:0000244|PDB:2BLL}.
FT   HELIX       574    586       {ECO:0000244|PDB:2BLL}.
FT   HELIX       591    593       {ECO:0000244|PDB:2BLL}.
FT   STRAND      600    602       {ECO:0000244|PDB:2BLL}.
FT   HELIX       606    609       {ECO:0000244|PDB:1Z7E}.
FT   HELIX       624    630       {ECO:0000244|PDB:2BLL}.
FT   HELIX       638    652       {ECO:0000244|PDB:2BLL}.
SQ   SEQUENCE   660 AA;  74289 MW;  A430928AB4041FA3 CRC64;
     MKTVVFAYHD MGCLGIEALL AAGYEISAIF THTDNPGEKA FYGSVARLAA ERGIPVYAPD
     NVNHPLWVER IAQLSPDVIF SFYYRHLIYD EILQLAPAGA FNLHGSLLPK YRGRAPLNWV
     LVNGETETGV TLHRMVKRAD AGAIVAQLRI AIAPDDIAIT LHHKLCHAAR QLLEQTLPAI
     KHGNILEIAQ RENEATCFGR RTPDDSFLEW HKPASVLHNM VRAVADPWPG AFSYVGNQKF
     TVWSSRVHPH ASKAQPGSVI SVAPLLIACG DGALEIVTGQ AGDGITMQGS QLAQTLGLVQ
     GSRLNSQPAC TARRRTRVLI LGVNGFIGNH LTERLLREDH YEVYGLDIGS DAISRFLNHP
     HFHFVEGDIS IHSEWIEYHV KKCDVVLPLV AIATPIEYTR NPLRVFELDF EENLRIIRYC
     VKYRKRIIFP STSEVYGMCS DKYFDEDHSN LIVGPVNKPR WIYSVSKQLL DRVIWAYGEK
     EGLQFTLFRP FNWMGPRLDN LNAARIGSSR AITQLILNLV EGSPIKLIDG GKQKRCFTDI
     RDGIEALYRI IENAGNRCDG EIINIGNPEN EASIEELGEM LLASFEKHPL RHHFPPFAGF
     RVVESSSYYG KGYQDVEHRK PSIRNAHRCL DWEPKIDMQE TIDETLDFFL RTVDLTDKPS
//
